On Tuesday, Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy (DMD) patients amenable to exon 53 skipping ...
Wave Life Sciences Ltd. (NASDAQ:WVE) released data from the Phase 2 FORWARD-53 trial of WVE-N531, which is an exon-skipping oligonucleotide being investigated in boys with Duchenne muscular dystrophy ...
Background Literature on shear wave elastography (SWE) assessing elasticity in rotator cuff (RC) muscles is growing. However, little is known about the overall measurement properties, which is crucial ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果